Urology

2022

1. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E

   Bladder Cancer, Vol. 8, Núm. 4, pp. 379-393

2. Advances in Urologic Oncology “OncoUrology Forum Special Edition”: The best of 2020

   Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 214-222

3. Current trends in erectile rehabilitation after radical prostatectomy: Results from a worldwide survey

   Andrologia, Vol. 54, Núm. 9

4. Cytotoxicity Assessment of a New Design for a Biodegradable Ureteral Mitomycin Drug-Eluting Stent in Urothelial Carcinoma Cell Culture

   Polymers, Vol. 14, Núm. 19

5. Decision-Making, Preference, and Treatment Choice for Asymptomatic Renal Stones-Balancing Benefit and Risk of Observation and Surgical Intervention: A Real-World Survey Using Social Media Platform

   Journal of Endourology, Vol. 36, Núm. 4, pp. 522-527

6. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study

   Neurourology and Urodynamics, Vol. 41, Núm. 8, pp. 1824-1833

7. Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk

   Prostate Cancer and Prostatic Diseases, Vol. 25, Núm. 2, pp. 274-282

8. El Dr. Piga y su propuesta médico-política

   Cadernos de atención primaria, Vol. 28, Núm. 1, pp. 16-20

9. Emergency upper urinary tract decompression: double-J stent or nephrostomy? A European YAU/ESUT/EULIS/BSIR survey among urologists and radiologists

   World Journal of Urology, Vol. 40, Núm. 7, pp. 1629-1636

10. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones

    European Urology Focus, Vol. 8, Núm. 5, pp. 1461-1468

11. Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents

    European Urology Open Science, Vol. 45, pp. 44-49

12. Impact of a radical prostatectomy on the urodynamic results of prostate cancer patients treated with intensity modulated radiation therapy

    Actas Urologicas Espanolas, Vol. 46, Núm. 7, pp. 431-441

13. Improved Survival with Enzalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Journal of Clinical Oncology, Vol. 37

14. Intraductal Carcinoma of the Prostate without High-Grade Invasive Adenocarcinoma: Report of Two Cases and Review of the Literature

    Archivos Espanoles de Urologia, Vol. 75, Núm. 9, pp. 738-745

15. Non-metastatic castration-resistant prostate cancer: management recommendations

    Actas Urologicas Espanolas, Vol. 46, Núm. 4, pp. 193-213

16. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis

    Actas Urologicas Espanolas, Vol. 46, Núm. 10, pp. 600-605

17. Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

    European Urology Open Science, Vol. 45, pp. 12-22

18. Single-port robot-assisted retroperitoneal surgery: A feasible approach

    Actas Urologicas Espanolas, Vol. 46, Núm. 10, pp. 653-657

19. The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups

    Prostate, Vol. 82, Núm. 13, pp. 1237-1247

20. The impact of psychiatric pathology on the prognosis and survival of men with prostate cancer undergoing radical prostatectomy

    Actas Urologicas Espanolas, Vol. 46, Núm. 10, pp. 646-652